Cross-border VC SRI Capital focuses on early-stage, cross-border investments between the US and India, presenting a strong opportunity to market enterprise software, compliance, and localization solutions that cater to both markets and can scale in a subscription model.

Industry focus Active interest in enterprise software and deep tech with scalable, capital-efficient product development. Target vendors offering subscription-based solutions to global enterprises, ideal for upsell to SRI's portfolio companies seeking rapid growth.

Active investor SRI positions itself as a hands-on, active investor that can facilitate introductions to US and Indian enterprise customers, potential co-investors, and strategic partners, aiding early customer acquisition and market expansion.

Recent portfolio signals Past investments include Meddo and Spoonshot, highlighting appetite for healthtech and AI-driven market intelligence; opportunities exist for solutions in healthtech, AI, data analytics, and consumer-facing enterprise tools integrated with healthcare and food industries.

Geographic footprint Offices in Philadelphia and Hyderabad, indicating a dual-market access point; sales motions can emphasize pan-continental go-to-market services, regional compliance, and support to accelerate customer onboarding in both the US and India.